Novartis AG (NVS)
103.85
+0.76
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
104.78
+0.93
(+0.90%)
Pre-Market: 08:30
Novartis Total Assets (Quarterly): 103.52B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 103.52B |
| June 30, 2024 | 97.50B |
| March 31, 2024 | 94.33B |
| December 31, 2023 | 99.94B |
| September 30, 2023 | 112.70B |
| June 30, 2023 | 110.98B |
| March 31, 2023 | 112.24B |
| December 31, 2022 | 117.45B |
| September 30, 2022 | 118.46B |
| June 30, 2022 | 122.91B |
| March 31, 2022 | 125.22B |
| December 31, 2021 | 131.80B |
| September 30, 2021 | 121.21B |
| June 30, 2021 | 124.02B |
| March 31, 2021 | 121.75B |
| December 31, 2020 | 127.78B |
| September 30, 2020 | 129.68B |
| June 30, 2020 | 123.76B |
| March 31, 2020 | 123.10B |
| December 31, 2019 | 118.37B |
| September 30, 2019 | 115.97B |
| June 30, 2019 | 116.29B |
| March 31, 2019 | 137.95B |
| December 31, 2018 | 145.56B |
| September 30, 2018 | 142.99B |
| Date | Value |
|---|---|
| June 30, 2018 | 142.06B |
| March 31, 2018 | 135.52B |
| December 31, 2017 | 133.08B |
| September 30, 2017 | 134.97B |
| June 30, 2017 | 133.75B |
| March 31, 2017 | 131.99B |
| December 31, 2016 | 130.12B |
| September 30, 2016 | 134.01B |
| June 30, 2016 | 131.44B |
| March 31, 2016 | 132.45B |
| December 31, 2015 | 131.56B |
| September 30, 2015 | 132.93B |
| June 30, 2015 | 135.41B |
| March 31, 2015 | 134.94B |
| December 31, 2014 | 125.39B |
| September 30, 2014 | 125.38B |
| June 30, 2014 | 125.77B |
| March 31, 2014 | 125.33B |
| December 31, 2013 | 126.25B |
| September 30, 2013 | 124.59B |
| June 30, 2013 | 121.07B |
| March 31, 2013 | 121.01B |
| December 31, 2012 | 124.19B |
| September 30, 2012 | 121.22B |
| June 30, 2012 | 118.49B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
94.33B
Minimum
Mar 2024
131.80B
Maximum
Dec 2021
116.84B
Average
119.84B
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 104.92B |
| Johnson & Johnson | 178.29B |
| Eli Lilly and Co | 75.61B |
| Novo Nordisk AS | 59.53B |
| Monte Rosa Therapeutics Inc | 315.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.08B |
| Shareholders Equity (Quarterly) | 43.32B |
| Debt to Equity Ratio | 0.6999 |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.33% |